Cyclic Vomiting Syndrome: Clinical Trials

12 trials for Cyclic Vomiting Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 recruiting, 2 terminated, 1 withdrawn. 7 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 3, Recruiting 3, Terminated 1
Phase 21Completed 1
Phase 31Terminated 1

Follow Cyclic Vomiting Syndrome: new trials by email Literature Review of Cyclic Vomiting Syndrome trials Research Report on Cyclic Vomiting Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Auricular Neurostimulation for Children With Cyclic Vomiting Syndrome
Active percutaneous electrical nerve field stimulation, Sham percutaneous electrical nerve field stimulation - Cyclic Vomiting Syndrome
Not applicableRecruitingMedical College of Wisconsin1202026-02-112026-03-16
Autonomic Reactivity and Personalized Neurostimulation
Percutaneous electrical nerve field stimulation, Hypnotherapy - Functional Gastrointestinal Disorders (FGIDs), Cyclic Vomiting Syndrome
Not applicableRecruitingMedical College of Wisconsin1202025-01-242026-02-13
Heartfulness Meditation (HFM) in Cyclic Vomiting Syndrome (CVS)
Heartfulness meditation - Cyclic Vomiting Syndrome
Not applicableCompletedOhio State University452022-06-062025-02-14
Cortical Excitability in Cyclic Vomiting Syndrome
TMS Paired-Pulse assessment of cortical excitability, Autonomic activity - Cyclic Vomiting Syndrome
Not applicableRecruitingUniversity of Pittsburgh1102022-05-162026-08-14
Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis
Droperidol, Haloperidol, Ondansetron 8mg - Cyclic Vomiting Syndrome
Phase 3TerminatedCorewell Health South322021-08-302025-05-21
Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome
3mg AZ-010, 1mg AZ010, Staccato Placebo - Cyclic Vomiting Syndrome
Phase 2CompletedAlexza Pharmaceuticals, Inc.1502021-02-052025-06-11
Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.
The Bridge device - Cyclic Vomiting Syndrome
Not applicableTerminatedMedical College of Wisconsin42019-04-232026-04-02
Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
Ensure - Cyclic Vomiting Syndrome
CompletedThe Cleveland Clinic242018-02-012020-02-27
Auricular Neurostimulation for Cyclic Vomiting Syndrome
Percutaneous neurostimulation - Cyclic Vomiting Syndrome, Abdominal Migraine
Not applicableCompletedMedical College of Wisconsin472018-01-312026-02-13
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
Q10 Coenzyme - Cyclic Vomiting Syndrome
CompletedCentral Hospital, Nancy, France152016-12-012017-09-28
Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS
Integrative healt care - Cyclic Vomiting Syndrome
Not applicableCompletedMedical College of Wisconsin742016-10-052020-04-01
The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)
Cyclic Vomiting Syndrome
WithdrawnMedical College of Wisconsin2007-10-012017-02-06

Narrower conditions

Familial cyclic vomiting syndrome (12)  ·  Migraine Disorders (2)  ·  Abdominal Pain (1)  ·  Autonomic Nervous System Diseases (1)  ·  Foodborne Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Nausea (1)  ·  Primary Dysautonomias (1)  ·  Vomiting (1)

Broader conditions

Nervous System Diseases (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Headache Disorders (2)  ·  Headache Disorders, Primary (2)  ·  Chemically-Induced Disorders (1)  ·  Digestive System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Poisoning (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Droperidol (1)  ·  Haloperidol (1)  ·  Hypnosis (1)  ·  Ondansetron (1)  ·  Ubiquinone (1)

Sponsors

Medical College of Wisconsin (6)  ·  Alexza Pharmaceuticals, Inc. (1)  ·  Central Hospital, Nancy, France (1)  ·  Corewell Health South (1)  ·  Ohio State University (1)  ·  The Cleveland Clinic (1)  ·  University of Pittsburgh (1)

Countries

United States (10)  ·  France (1)

Top investigators

B Li, MD (1)  ·  David J Levinthal, MD PhD (1)  ·  Gila Ginzburg, MD (1)  ·  Katja Karrento, MD (1)  ·  Katja Kovacic, MD (1)  ·  Larry Carter, PhD (1)  ·  Scott Gabbard, MD (1)  ·  Thangam Venkatesan (1)

Results publications

PMID 37389229, PMID 38713142

NIH funding

R01DK140255 (1)